The Time To Act campaign, organised by the European Cancer Organisation (ECO) in collaboration with the global public affairs agency BCW, has been recognised with the prestigious Excellence in Communicating and Using Data Award at the annual Communiqué Awards, which highlights best practices in healthcare messaging across Europe.
The campaign organised by ECO’s Special Network on the Impact of Covid-19 on Cancer raised public awareness on the pandemic’s staggering disruption of cancer care and how it may have resulted in more than one million cancer cases being missed in Europe. The campaign’s overarching message to patients was; Don’t let Covid-19 stop you from tackling Cancer.
To ensure this echoed across Europe, ECO translated campaign material into 30 languages and organised a main launch event as well as 12 national launch events in Poland, Italy, Spain, Romania, Malta, France, Croatia, Cyprus, Slovenia, Portugal, Slovakia, and Ireland. Each launch featured national Health Ministers and MEPs, all dedicated to alleviating the burden of Covid-19 on essential cancer care.
The Time To Act campaign continues to add new features to its Data Navigator, a visualisation tool displaying key data on the pandemic’s impact on cancer care within the European region, with a major upgrade scheduled for release after the summer, including for the first time, data intelligence specific to tumour types and from 30 European countries.
Commenting on winning the award, Andreas Charalambous, ECO President, said: “It is a great honour for Time To Act to be recognised in this way. The campaign conveys our rapid response to an ongoing healthcare emergency that has significantly impacted cancer care around the world. My gratitude goes to all of those who supported and keep supporting this initiative within the EU and beyond."
Professor Mark Lawler, co-chair of the Special Network on the Impact of Covid-19 on Cancer and a professor of Digital Health at Queen’s University Belfast, said: “The award recognises how we deployed data intelligence and innovative communication to highlight the disastrous impact of Covid-19 on cancer patients and services. It also highlights the fact that unless we act quickly and decisively, the Covid-19 pandemic will undoubtedly trigger a future cancer epidemic.”
“With Time to Act we aim to spread awareness about the negative effects of the Covid-19 pandemic on cancer care” said Mirjam Crul, Co-chair of the Special Network on the Impact of Covid-19 on Cancer and European Society of Oncology Pharmacy (ESOP) vice-president. “With the help of many engaged politicians, patient advocacy groups and local cancer organisations, we were able to reach out to many.”
Please click these links for more information on the Special Network on the Impact of Covid-19 on Cancer and the Time To Act campaign in 30 languages.